Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial - Poll - MDSpire

Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial

  • By

  • Demet Özcan

  • Patricia Switten Nielsen

  • Jan Alsner

  • Mette Holck Nielsen

  • Else Maae

  • Marie Louise Holm Milo

  • Jens Overgaard

  • Birgitte Vrou Offersen

  • Trine Tramm

  • March 13, 2026

  • 0 min

Share

Original Source(s)

Correlation of Tumor Immune Response with Prognosis in Node-Negative Breast Cancer Patients from the DBCG HYPO Randomized Trial

  • by Demet Özcan, Patricia Switten Nielsen, Jan Alsner, Mette Holck Nielsen, Else Maae, Marie Louise Holm Milo, Jens Overgaard, Birgitte Vrou Offersen, Trine Tramm

  • March 13, 2026

Related Content

Lactylation-mediated remodelling of the breast cancer microenvironment: single-cell multidimensional analysis and prognostic model construction

Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

Case Report: A case of a pregnancy-associated breast cancer patient with a pathogenic variant in BRCA1 who underwent staged risk-reducing salpingo-oophorectomy and contralateral risk-reducing mastectomy